Petosemtamab in combination with FOLFOX /FOLFIRI (1L and 2L mCRC) and as monotherapy (3L+ mCRC), demonstrates antitumor activity and a ...
Colorectal cancer (CRC) is one of the most common malignant cancers and its incidence is steadily rising particularly in ...
Three presentations at ESMO 2025 will demonstrate Lunit SCOPE IO’s value in predicting immunotherapy response in colorectal, ...
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In ...
First-line encorafenib + cetuximab + mFOLFOX6 in BRAF V600E-mutant metastatic colorectal cancer (BREAKWATER): Progression-free survival and updated overall survival analyses. Association between ...
Explore a potential trade with CytomX (CTMX) stock as Q1’26 clinical data approaches for its EpCAM-targeting therapy. Read ...
A new study from researchers at The University of Texas MD Anderson Cancer Center shows that the glucose-fructose mix found in sugary drinks directly fuels metastasis in preclinical models of advanced ...
Health on MSN
What Does Colon Cancer Pain Feel Like?
Colon cancer pain can happen in later stages of the condition as a tumor grows larger. Symptoms include pain in the abdomen ...
Poster presentation: Title: Preclinical evaluation of petosemtamab, an epidermal growth factor receptor (EGFR) and leucine-rich repeat-containing G protein-coupled receptor (LGR5) bispecific antibody, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback